Through an agreement signed with COVAX co-lead @gavi, @CloverBiopharma is set to make over 400 million doses of its #COVID19 vaccine available for procurement in 2021 and 2022, pending Emergency Use Listing from @WHO🌍
Here's more about our vaccine R&D partnership with Clover📺
We've been running a series of webinars for @NIHRresearch Health Protection Research Units on #knowledgemobilisation#communications & #publicinvolvement & created this table to help explain each one. Sharing as it may be useful to others! https://t.co/zC7Ayz80I1 (pdf downloads)
Today we welcomed @JimBethell at @PHE_uk Colindale where National Infection Service teams are working hard to expand our genomics capabilities to identify and control new variants of #COVID19 as soon as possible. Thank you all for your great work.
Delighted to present "Pervasive Surveillance during a global pandemic" in @bsimark & Mark O'Brien's IT, Law & Cyberspace stream @SLSA_UK#SLSA2021 a very thought provoking session. With thanks to @ShaneKil@AlanJCusack@ULSchoolofLaw@IrishResearch
https://t.co/cDNOddOQQG
Really looking forward to the PGR activities today at #SLSA2021@SLSA_UK and presenting my poster on Pervasive Surveillance: A discourse analysis of changing legal & social controls through surveillance techniques, thanks to @ULSchoolofLaw@ShaneKil@AlanJCusack & @IrishResearch
A few permanent and fixed term vacancies now available in RIPL:
Senior BMS and LSO (permanent)
https://t.co/GzRH7qNsoD
Specialist BMS (2x fixed term)
https://t.co/e9ORk4odXY
MLA (permanent)
https://t.co/4Z0lSNILgO
New year, new job?
#ibmschat@IBMScience